These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12424218)

  • 1. Selective neuronal degeneration induced by soluble oligomeric amyloid beta protein.
    Kim HJ; Chae SC; Lee DK; Chromy B; Lee SC; Park YC; Klein WL; Krafft GA; Hong ST
    FASEB J; 2003 Jan; 17(1):118-20. PubMed ID: 12424218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ 1-42 oligomer injection.
    Choi JG; Moon M; Kim HG; Mook-Jung I; Chung SY; Kang TH; Kim SY; Lee EH; Oh MS
    Neurobiol Learn Mem; 2011 Sep; 96(2):306-14. PubMed ID: 21689771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid beta interacts with the amyloid precursor protein: a potential toxic mechanism in Alzheimer's disease.
    Lorenzo A; Yuan M; Zhang Z; Paganetti PA; Sturchler-Pierrat C; Staufenbiel M; Mautino J; Vigo FS; Sommer B; Yankner BA
    Nat Neurosci; 2000 May; 3(5):460-4. PubMed ID: 10769385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies.
    Kirkitadze MD; Bitan G; Teplow DB
    J Neurosci Res; 2002 Sep; 69(5):567-77. PubMed ID: 12210822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker evidence for uncoupling of amyloid build-up and toxicity in Alzheimer's disease.
    Zetterberg H; Blennow K
    Alzheimers Dement; 2013 Jul; 9(4):459-62. PubMed ID: 23159047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicity mediated by soluble oligomers of beta-amyloid(1-42) on cholinergic SN56.B5.G4 cells.
    Heinitz K; Beck M; Schliebs R; Perez-Polo JR
    J Neurochem; 2006 Sep; 98(6):1930-45. PubMed ID: 16945109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
    Lilja AM; Porras O; Storelli E; Nordberg A; Marutle A
    J Alzheimers Dis; 2011; 23(2):335-47. PubMed ID: 21116052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. {beta}-Amyloid-induced neurodegeneration and protection by structurally diverse microtubule-stabilizing agents.
    Michaelis ML; Ansar S; Chen Y; Reiff ER; Seyb KI; Himes RH; Audus KL; Georg GI
    J Pharmacol Exp Ther; 2005 Feb; 312(2):659-68. PubMed ID: 15375176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aβ toxicity in primary cultured neurons.
    Ferreira A; Sinjoanu RC; Nicholson A; Kleinschmidt S
    Methods Mol Biol; 2011; 670():141-53. PubMed ID: 20967589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.
    Watson D; Castaño E; Kokjohn TA; Kuo YM; Lyubchenko Y; Pinsky D; Connolly ES; Esh C; Luehrs DC; Stine WB; Rowse LM; Emmerling MR; Roher AE
    Neurol Res; 2005 Dec; 27(8):869-81. PubMed ID: 16354549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal receptors as targets for the action of amyloid-beta protein (Aβ) in the brain.
    Patel AN; Jhamandas JH
    Expert Rev Mol Med; 2012 Jan; 14():e2. PubMed ID: 22261393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β25-35 induces apolipoprotein D Synthesis and growth arrest in HT22 hippocampal cells.
    Martínez E; Navarro A; Ordóñez C; Del Valle E; Tolivia J
    J Alzheimers Dis; 2012; 30(2):233-44. PubMed ID: 22398376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Secretase, APP and Abeta in Alzheimer's disease.
    Vassar R
    Subcell Biochem; 2005; 38():79-103. PubMed ID: 15709474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane cholesterol interferes with neuronal apoptosis induced by soluble oligomers but not fibrils of amyloid-beta peptide.
    Sponne I; Fifre A; Koziel V; Oster T; Olivier JL; Pillot T
    FASEB J; 2004 May; 18(7):836-8. PubMed ID: 15001562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid beta precursor protein.
    Heredia L; Lin R; Vigo FS; Kedikian G; Busciglio J; Lorenzo A
    Neurobiol Dis; 2004 Aug; 16(3):617-29. PubMed ID: 15262274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LPYFDa neutralizes amyloid-beta-induced memory impairment and toxicity.
    Granic I; Masman MF; Kees Mulder C; Nijholt IM; Naude PJ; de Haan A; Borbély E; Penke B; Luiten PG; Eisel UL
    J Alzheimers Dis; 2010; 19(3):991-1005. PubMed ID: 20157254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.